Skip to main content
. 2022 May 2;12(5):e049225. doi: 10.1136/bmjopen-2021-049225

Table 1.

Baseline visits and follow-ups

Measure Baseline Biennial follow-up
Demographic information (sex, age, nationality, marriage, education, monthly salary, occupation)
Disease history (eg, MI, CAD, cardiomyopathy, valvular heart disease)
Intervention (eg, PCI, CABG, CRT/ICD, valvular surgery, TAVI, ventricular aneurysm surgery)
Arrhythmia (atrial/ventricular premature beats, atrial flutter, atrial fibrillation, ventricular tachycardia, sick sinus syndrome, atrioventricular block)
Medication history (eg, aspirin, P2Y12 inhibitors, ACEI/ARB/ARNI, β-blocker, CCB, statins, diuretic, aldosterone receptor antagonist, digoxin, amiodarone)
Comorbidity (hypertension, diabetes mellitus, dyslipidaemia, stroke, chronic kidney disease, thyroid disease, pulmonary diseases)
Family history of cardiovascular diseases or metabolic abnormalities
Dietary pattern (eg, food type, food frequency and flavour)
Lifestyle behaviours (eg, tea, coffee and alcohol consumption)
Sleep duration, sleep quality, snoring, the use of sleeping pills
Muscle function and strength (eg, SARC-F questionnaire, handgrip and limb muscle strength)
Bowel movements (eg, stool frequency, constipation and the use of laxative)
Physical activity (eg, exercise type, exercise frequency and exercise duration)
Physical examination (eg, height, weight, waist and hip circumference and blood pressure)
HF symptoms (acute/chronic HF, Killip class, NYHA class, nausea/vomiting and oedema)
Cardiac imaging test (coronary angiography/electrocardiography, echocardiography and cardiac magnetic resonance)
Chest CT, vascular ultrasonography, ABI, PWV
Blood biochemical parameters (WBC, RBC, platelets, glucose and insulin, HbA1c, lipid profile, creatinine and uric acid, pro-BNP, thyroxine, interleukin, hs-CRP, myocardial enzymes, tumour necrosis factor, tumour markers, ferritin)
Urine sample (urine protein, microalbuminuria, creatinine and albumin/creatinine)

ABI, ankle brachial index; ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor-neprilysin inhibitor; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCB, calcium channel blocker; CRT, cardiac resynchronisation therapy; HbA1c, haemoglobin A1c; hs-CRP, high-sensitivity C reactive protein; ICD, implantable cardioverter-defibrillator; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; pro-BNP, pro-brain natriuretic peptide; PWV, pulse wave velocity; RBC, red blood cell; TAVI, transcatheter aortic valve implantation; WBC, white blood cell.